Insiders

05/02 IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer CI
29/01 Ipsen Nominates Peter Guenter to its Board of Directors, Effective January 28, 2026 CI
28/01 Vallourec, Mersen, Delfingen... Stocks to Watch Tomorrow in Paris Zonebourse
16/01 Arch Biopartners Inc. Announces Appointment of Patrick Vink as Chairman of the Board and Retirement of Claude Allary from the Board of Directors CI
16/01 Sector Update: Health Care Stocks Softer in Afternoon Trading MT
13/01 Gan & Lee Pharmaceuticals Appoints Dr. John Wang As Senior Vice President And Chief Strategy Officer, Effective January 12, 2026 CI
08/01 Alveus Therapeutics ApS announced that it has received $159.8 million in funding from New Rhein Healthcare Investors, LLC, Andera Partners, Omega Fund Management, LLC, Kurma Partners SA, Avego BioScience Capital, Sanofi and other investors CI
08/01 Alveus Therapeutics, Inc. announced that it has received $159.8 million in funding from New Rhein Healthcare Investors, LLC, Andera Partners, Omega Fund Management, LLC, Kurma Partners SA, Avego BioScience Capital, Sanofi and other investors CI
06/01 Compass Therapeutics, Inc. Announces Executive Appointments, Effective as of January 1, 2026 CI
17/12 Koru Medical Systems Names Eric Schiller as CTO MT
17/12 KORU Medical Systems, Inc. Appoints Eric Schiller As Chief Technology Officer, Effective December 29, 2025 CI
02/12 Ovid Therapeutics Inc. Appoints Petra Kaufmann as Chief Medical Officer CI
01/12 Tyra Biosciences, Inc. Appoints Heather Faulds as Chief Regulatory Officer, Effective December 8, 2025 CI
26/11 CG Oncology, Inc. Announces Board and Committee Changes CI
21/11 French and Benelux stocks-Factors to watch 21 Nov RE
10/11 Cingulate Inc. Appoints Bryan Downey as Chief Commercial Officer CI
31/25/31 DBV Technologies S.A. Appoints Philina Lee to the Board of Directors and Member of the Compensation Committee, Effective October 30, 2025 CI
27/25/27 Sanofi India Limited Announces Managing Director Changes CI
09/25/09 Alten S.A. Announces Board Changes CI
08/25/08 BioVaxys Appoints James Tartaglia to Board MT
08/25/08 Biovaxys appoints former Sanofi Vaccines executive to board of directors RE
07/25/07 Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise CI
29/25/29 GSK commercial chief to become CEO at start of "pivotal" 2026 AN
05/25/05 Revolut Appoints Frédéric Oudéa as Chairman of Upcoming Western Europe Subsidiary RE
18/25/18 Blueprint Medicines Corporation Announces Directorate and Committee Changes CI
No results for this search